FDA Warning Letter — Bella Pharmaceuticals, Inc.

Case 572550 — FEI 3013442632

The FDA took a Warning Letter action against Bella Pharmaceuticals, Inc. on Feb 11, 2019 (Glenview, IL). The action was issued by CDER and concerns drugs products. This facility has 1 recent FDA inspection on record.

Action details

Facility
Bella Pharmaceuticals, Inc.
Date
Feb 11, 2019
Fiscal Year
2019
Product Type
Drugs
Center
CDER
Location
Glenview, IL (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.